Full Text
HTA63 Cost-Effectiveness of Empagliflozin in the Treatment of Patients With Chronic Kidney Disease in France

Abstract

Authors

R Supiot J Tardu N Virely M Sivignon J Chollet A Uster P Lévy Z Massy

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×